🔎 Trials Near Me

Akèy › Leukemi › Kalifòni › Orange

Etid klinik pou Leukemi nan Orange, CA

7 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Ap rekriteFaz 3
  • University of California, Irvine, Orange
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07007312

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Children's Hospital Orange County, Orange
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Ap rekriteFaz 2
  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Orange
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Leukemi nan lòt vil

Lòt etid nan Orange

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.